Publication:
The IDH-TAU-EGFR triad defines the neovascular landscape of diffuse gliomas

dc.contributor.affiliation"Centro de Biología Molecular “Severo Ochoa” (CSIC-UAM), Madrid, 28049, Spain"," Neurooncology Unit, Instituto de Salud Carlos III-UFIEC, Madrid, 28220, Spain"," Facultad de Medicina de la Universidad Francisco de Vitoria, Madrid, 28223, Spain"," Dto. de Anatomía, Histología y Neurociencia, Facultad de Medicina de la Universidad Autónoma, Madrid, 28029, Spain"," Department of Neurosurgery, Department of Cell and Developmental Biology, University of Michigan, School of Medicine, Ann Arbor, MI 48109, United States"," Dto. Neurocirugía, Hospital 12 de Octubre, Univ. Complutense, Madrid, 28041, Spain"," Instituto de Investigaciones Biomédicas I+12, Hosp. 12 de Octubre, Madrid, 28041, Spain"," Fundación de Investigación HM Hospitales, HM Hospitales, Madrid, 28015, Spain"," Facultad de Medicina (IMMA), Universidad San Pablo-CEU, Madrid, 28925, Spain"," IMDEA Nanoscience, Madrid, 28049, Spain"," Vall d'Hebron Institute of Oncology (VHIO), Barcelona, 08035, Spain"," Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), ISCIII, Madrid, 28029, Spain"," Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, 08010, Spain"," Unidad de Oncología Molecular, CIEMAT, Madrid, 28040, Spain"," Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), ISCIII, Madrid, 28029, Spain"en
dc.contributor.affiliation000000041762408X
dc.contributor.authorGargini R.
dc.contributor.authorSegura-Collar B.
dc.contributor.authorHerránz B.
dc.contributor.authorGarcía-Escudero V.
dc.contributor.authorRomero-Bravo A.
dc.contributor.authorNúñez F.J.
dc.contributor.authorGarcía-Pérez D.
dc.contributor.authorGutiérrez-Guamán J.
dc.contributor.authorAyuso-Sacido A.
dc.contributor.authorSeoane J.
dc.contributor.authorPérez-Núñez A.
dc.contributor.authorSepúlveda-Sánchez J.M.
dc.contributor.authorHernández-Laín A.
dc.contributor.authorCastro M.G.
dc.contributor.authorGarcía-Escudero R.
dc.contributor.authorÁvila J.
dc.contributor.authorSánchez-Gómez P.
dc.date.accessioned2020-12-09T11:55:02Z
dc.date.available2020-12-09T11:55:02Z
dc.date.issued2020
dc.identifier.doi10.1126/scitranslmed.aax1501en
dc.identifier.urihttp://hdl.handle.net/20.500.12614/1889
dc.issue.numbereaax1501en
dc.journal.titleScience Translational Medicineen
dc.language.isoenen
dc.relation.projectIDTEMP"This work was supported by NIH/ NINDS grants R01-NS105556 and R37-ND094804 to M.G.C."," by Ministerio de Econom?a y Competitividad (Acci?n Estrat?gica en Salud) grants PI13/01258 to A.H.-L., PI17/01489 and CP11/00147 to A.A.-S., PI18/00263 to R.G.-E., and PI16/01 278 to J.S."," by ?Asociaci?n Espa?ola contra el Cancer? grants Investigador Junior to R.G. and GCTRA16015SEDA to J.M.S.-S. and J.S."," and by Ministerio de Econom?a y Competitividad SAF-2014-53040-P to J.A., RTC-2015-3771-1 to J.S., and SAF2015-65175-R/FEDER to P.S.-G."
dc.rightsAtribución-NoComercial-SinDerivadas 3.0 España*
dc.rights.accessRightsopen accessen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.titleThe IDH-TAU-EGFR triad defines the neovascular landscape of diffuse gliomasen
dc.typeresearch articleen
dc.volume.number12en
dspace.entity.typePublication

Files

Collections